| RS201666606 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS201666755 |
PLOD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201666889 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS201667254 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS201667363 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Monogenic diabetes |
| RS201667603 |
MBTPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201668897 |
APP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease, Inborn genetic diseases |
| RS201668928 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, TRPM1-related disorder |
| RS201669114 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peripheral neuropathy, PLEKHG5-related disorder |
| RS201669522 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 2, Wolff-Parkinson-White pattern |
| RS201669595 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, 8 conditions |
| RS201669763 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS201670044 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS201670299 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, MYO5B-related disorder |
| RS201670423 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia |
| RS201670483 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS201670662 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS201670791 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS201671013 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS201671098 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS201671325 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS201671392 |
IL7R
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2016714761 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS201671566 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Gastric cancer |
| RS201671718 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS201671992 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, DNAH11-related disorder |
| RS201672011 |
APOE
|
Health Risk |
Conflicting classifications of pathogenicity |
APOE5 VARIANT, 6 conditions |
| RS201672132 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201672517 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS201672777 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS201673334 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS201673771 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS201673987 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Benign familial hematuria |
| RS201674226 |
EPB41
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 1, Lymphoma |
| RS201674363 |
CTPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to CTPS1 deficiency, Combined immunodeficiency due to CTPS1 deficiency |
| RS201674366 |
CELF2
|
Health Risk |
Likely pathogenic |
CELF2-related disorder, CELF2-related disorder |
| RS201674457 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1 |
| RS201674667 |
SPINK5
|
Health Risk |
Pathogenic |
Netherton syndrome, Ichthyosis linearis circumflexa |
| RS201674674 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS201674835 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Inborn genetic diseases |
| RS201674874 |
EPB42
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 5, Inborn genetic diseases |
| RS201674914 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS201675191 |
INTS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, INTS1-related disorder |
| RS201675352 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, COL2A1-related disorder |
| RS201675394 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CCDC88C-related disorder |
| RS201675499 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, FRAS1-related disorder |
| RS201675886 |
OFD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofaciodigital syndrome I, Joubert syndrome |
| RS201675947 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS201675951 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS201676429 |
NPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastric cancer, Gastric cancer |
| RS201676628 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS201676629 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 2, Retinitis pigmentosa |
| RS201676770 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS2016767710 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS201676898 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS201676960 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder |
| RS201677317 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia |
| RS201677553 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS201677741 |
TINF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 3 |
| RS201677978 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS201678207 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Majeed syndrome, Inborn genetic diseases |
| RS201678228 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Hereditary hemorrhagic telangiectasia |
| RS201678262 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2016789960 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS201679112 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 2, Autosomal dominant polycystic kidney disease |
| RS201679198 |
LONP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201679510 |
MMP2
|
Health Risk |
Likely pathogenic |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS201679731 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS201679831 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hypothermia, Malignant hyperthermia |
| RS201680145 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS201681256 |
HERC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201681328 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Heterotopia |
| RS201681639 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS201681832 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
TRIOBP-related disorder, TRIOBP-related disorder |
| RS201681875 |
SLC39A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary acrodermatitis enteropathica, Hereditary acrodermatitis enteropathica |
| RS201682029 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile cortical hyperostosis, Ehlers-Danlos syndrome |
| RS201682200 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Jervell and Lange-Nielsen syndrome 1, Atrial fibrillation |
| RS201682415 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS201682634 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS201683491 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201683794 |
HOGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS201683984 |
TNFRSF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TNF receptor-associated periodic fever syndrome (TRAPS), Autoinflammatory syndrome |
| RS201684129 |
NPIPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201684605 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS201684653 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS201684898 |
CCDC39
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 14 |
| RS201685063 |
SFTPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease 2, Surfactant metabolism dysfunction |
| RS201685079 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201685429 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS201685625 |
PSMD12
|
Health Risk |
Conflicting classifications of pathogenicity |
Stankiewicz-Isidor syndrome, Inborn genetic diseases |
| RS201685731 |
GPIHBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipoproteinemia, type 1D |
| RS201685748 |
ARFGEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS201685981 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Ovarian serous cystadenocarcinoma |
| RS201686029 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS201686383 |
SNORD118
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy with calcifications and cysts, Leukoencephalopathy with calcifications and cysts |
| RS201686470 |
AP2S1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2016866550 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS201686865 |
FGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial visceral amyloidosis, Ostertag type |
| RS2016868693 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS201686887 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |